The Effect of Motivational Interviewing in Women's Health

July 31, 2026 updated by: Amasya University

The Effect of Motivational Interviewing on Behaviour of Healthcare Demand Procrastination, Health Beliefs Regarding Cervical Cancer Screenings, and Screening Participation in Women

The behaviour of healthcare demand procrastination constitutes an obstacle for individuals to lead a healthy life, and an example of this is the low participation rate of women in pap-smear screening programs compared to the target population. It is known that motivational interviews are frequently used and effective in studies planned to change health behavior. According to the results of the power analysis, at least 104 women, 52 experimental and 52 control, should be included in the study. Data will be collected with the "Personal Information Form", "Healthcare Demand Procrastination Scale", "Health Belief Model Scale for Cervical Cancer and Pap Smear Test" and "Evaluation Form for Cervical Cancer Screening Participation". Motivational interviews will be given to the women in the experimental group.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The behaviour of healthcare demand procrastination constitutes an obstacle for individuals to lead a healthy life, and an example of this is the low participation rate of women in pap-smear screening programs compared to the target population. It is known that motivational interviews are frequently used and effective in studies planned to change health behavior. This study aims to evaluate the effectiveness of motivational interviewing on behaviour of healthcare demand procrastination, health beliefs regarding cervical cancer screenings, and screening participation in women. According to the results of the power analysis, at least 104 women, 52 experimental and 52 control, should be included in the study. Data will be collected with the "Personal Information Form", "Healthcare Demand Procrastination Scale", "Health Belief Model Scale for Cervical Cancer and Pap Smear Test" and "Evaluation Form for Cervical Cancer Screening Participation". Motivational interviews will be given to the women in the experimental group by the researcher once a week for 4 weeks.

Study Type

Interventional

Enrollment (Actual)

118

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The ages of 30-65,
  • Having not had cervical cancer screening before,
  • Having not had a hysterectomy operation,
  • Being literate,
  • Volunteering to participate in the study

Exclusion Criteria:

  • Those who have communication problems,
  • Those with psychiatric and mental illnesses,
  • Those who have previously attended any training on cervical cancer screening,
  • Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Control
Experimental: Experimental group
Motivational Interviews
Behavioral: Experimental (Motivational Interviews)
Monitoring 'behaviour of healthcare demand procrastination, health beliefs regarding cervical cancer screenings, and screening participation' with motivational interviewing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare Demand Procrastination Scale
Time Frame: At the end of the 4 weeks
The minimum score that can be obtained from the scale is "11", the maximum score is "55", and as the score obtained from the scale increases, behaviour of healthcare demand procrastination also increase.
At the end of the 4 weeks
Health Belief Model Scale for Cervical Cancer and Pap Smear Test
Time Frame: At the end of the 4 weeks
The scale consists of 35 items and 5 sub-dimensions. Each sub-dimension in the scale is scored separately. A high mean score is evaluated positively, except for the 'pap smear barriers' sub-dimension. A high 'pap smear barriers' score indicates that there are problems with having a pap smear.
At the end of the 4 weeks
Cervical Cancer Screening Participation
Time Frame: At the end of the 6 months
Developed by the researcher. It is a two-question form that aims to evaluate women's cervical cancer screening behaviors in the last 6 months and the effectiveness of motivational interviewing on these behaviors.
At the end of the 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Amasya University

Investigators

  • Principal Investigator: Emine İbici Akça, Amasya University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Actual)

February 1, 2025

Study Completion (Actual)

May 31, 2025

Study Registration Dates

First Submitted

July 2, 2024

First Submitted That Met QC Criteria

July 9, 2024

First Posted (Actual)

July 10, 2024

Study Record Updates

Last Update Posted (Actual)

August 3, 2026

Last Update Submitted That Met QC Criteria

July 31, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Amasya Univer_emine.akca

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe